AML patients with AKI had lower albumin levels (3.2 g/dl, range 2.1–4.0, vs. 3.4 g/dl, range 2.25–4.25, p < 0.001) and higher CRP levels during the hospital stay of induction chemotherapy than AML patients without AKI (5.94 mg/dl, range 0.61–34.66, vs. 3.69 mg/dl, range 0.19–87.6, p < 0.001). This evidence concerns the gene ALB and acute kidney injury.